---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-006959"
form_type: "8-K"
ticker: "OPRX"
cik: "0001448431"
company_name: "OptimizeRx Corp"
filed_at: "2024-01-26T23:59:59+00:00"
generated_at: "2026-06-06T16:30:10.589926+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# OptimizeRx announces Chair retirement; Lynn O'Connor Vos appointed Chair, Catherine Klema added as director

## Summary
- Gus Halas retired as Chairperson effective Jan 24, 2024, after nearly a decade of service.
- Lynn O'Connor Vos appointed Chairperson, also joins Nominating & Governance, Compensation, and Audit committees.
- Board increased to 7 members; Catherine M. Klema appointed as director and member of Audit and Compensation committees.
- Klema receives annual cash retainer $40,000, equity grant $150,000, plus additional committee retainers ($10k Audit, $5k Comp).

## SEC filing metadata
- accession: 0001213900-24-006959
- form_type: 8-K
- ticker: OPRX
- cik: 0001448431
- company_name: OptimizeRx Corp
- filed_at: 2024-01-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1448431/000121390024006959/0001213900-24-006959-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1448431/000121390024006959/ea192296-8k_optimizerx.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-006959
- JSON: https://secwatch.observer/filing/0001213900-24-006959.json
- Plain text: https://secwatch.observer/filing/0001213900-24-006959.txt

## Key facts
- Executive change
  Catherine M. Klema was appointed as Director at OptimizeRx Corp.
  - Action: appointed
  - Role: Director
  source text: Effective January 24, 2024, the Board increased the size of the Board to seven (7) members and, upon the recommendation of the Board’s Nominating & Governance Committee, appointed Catherine M. Klema to serve as a director of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1448431/000121390024006959/0001213900-24-006959-index.htm
- Executive change
  Lynn O'Connor Vos was appointed as Chairperson of the Board at OptimizeRx Corp.
  - Action: appointed
  - Role: Chairperson of the Board
  source text: Effective January 24, 2024, the Board appointed Lynn O’Connor Vos, a director of the Company, to serve as Chairperson of the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/1448431/000121390024006959/0001213900-24-006959-index.htm
- Executive change
  Gus Halas retired as Chairperson of the Board at OptimizeRx Corp.
  - Action: retired
  - Role: Chairperson of the Board
  source text: Effective January 24, 2024, Gus Halas retired from his position as Chairperson of the Board of Directors
  evidence_url: https://www.sec.gov/Archives/edgar/data/1448431/000121390024006959/0001213900-24-006959-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.